Ro vs Noom

For compounded medication, yes, on the published figures. Noom's Microdose GLP-1Rx plan is $79 plus tax for a 3 week subscription with 4 weeks of medication, then $179 a month plus tax, medication included (checked November 8, 2026). Ro's lowest ongoing total at the starting dose is $298 a month on a monthly plan, or $223 with the membership prepaid for a year (checked November 8, 2026). The two are not like for like: Noom's figure buys a microdose of compounded medication, which is not FDA-approved, and Ro's buys a brand-name, FDA-approved product at its labeled starting dose.

For brand-name medication the comparison is closer than the headline suggests. Noom's FAQ prices its brand-name route as a telehealth plan "starting at" a figure below Ro's first month membership, plus whatever the medication costs you with or without insurance; Ro prices the membership ($39 for the first month, then $74 to $149 a month by plan) and publishes the cash price of every dose, from $149 for the Wegovy pill and $299 for Zepbound. Noom does not publish per dose cash prices for brand-name medication on the pages we read, so a brand-name total at Noom cannot be stated here. For Ro's figures over 3, 6 and 12 months, see the US GLP-1 price index.

Ro's weight-loss pages, read on October 18, 2026, list brand-name medicines only: the Wegovy pill and pen, the Foundayo pill, Zepbound and Ozempic. The word "compound" does not appear. A licensed provider decides which, if any, you are prescribed, and Ro says it only charges the membership if you are eligible.

Noom Med sells both. Its Noom GLP-1Rx and Microdose GLP-1Rx programs use compounded semaglutide and tirzepatide, about which Noom states: "any compounded medications are not approved by the FDA or reviewed for quality, safety or efficacy", and that its compounded semaglutide "is produced in an FDA-registered facility but has not been reviewed by the FDA for safety, efficacy, or quality" (noom.com, read October 29, 2026). Alongside them Noom lists brand-name Wegovy, the Wegovy pill, Zepbound, Ozempic, Mounjaro and Foundayo, generic liraglutide and metformin, which Noom notes is not FDA-approved for weight loss. The microdose plan, in Noom's words, "provides a smaller dose compared to our standard GLP-1 plan".

Ro's providers review an online intake and decide what, if anything, to prescribe; cash-pay medication ships to your door and insured medication is picked up at your pharmacy. Noom says its GLP-1Rx care is mainly asynchronous, by chat, with video visits in some programs, that it verifies identity and requires a full body photo and a medical intake before treatment, and that it ships medication in 7 days if prescribed. Noom does not name its compounding pharmacies: it describes "U.S. Pharmacopeia (USP)-compliant, state-regulated pharmacies" and says GLP-1Rx patients may request a certificate of analysis from its care team.

On refunds the two read differently but land in a similar place. Ro refunds the first month's membership if you are not eligible for GLP-1s; after that the membership is non-refundable once paid, prescription products are final sale, and you must cancel at least 48 hours before renewal. Noom's terms (read October 29, 2026) say all fees are non-refundable "except as expressly promoted by Noom", that there is no refund or credit for a partly used billing period, and that you must cancel before 11:59 pm Eastern on the day before your next billing date to avoid the next charge; California residents may rescind within three business days.

The public records: the BBB rates Ro A+ with 747 complaints in three years (read October 18, 2026) and Noom, Inc. A+, accredited since October 18, 2021, with 598 complaints in three years and 148 in the last twelve months (read October 29, 2026). Trustpilot shows 3.9 from 7,231 reviews for Ro (read October 18, 2026) and 4.5 from 67,189 for Noom (read October 29, 2026), where 60% are five star and 5% one star. Noom's profiles cover the whole Noom business, the app included, not Noom Med alone. We found no FDA warning letter addressed to either (fda.gov searches, October 18 and 29, 2026), which is "none found" rather than proof. The Ro review sets out the complaint themes behind Ro's figures.

Ro, on the facts above: someone who wants FDA-approved brand-name medication, wants the cash price of every dose published before they start, may want to try insurance first, and is content to pay a membership ($149 monthly or $74 a month prepaid) on top of it.

Noom Med, on the facts above: someone who wants the medication and the program priced as one figure ($179 a month on the microdose plan after the introductory period), is open to compounded medication at a lower dose, wants Noom's lessons, tracking and coaching around it, and lives in a state Noom serves. Someone who wants to know which pharmacy compounds their medication before paying will not find it named on Noom's pages.

This page does not rank one above the other, and none of it is medical advice: a licensed clinician decides whether GLP-1 treatment is appropriate for you. PCF may earn a commission if you sign up with Ro through the links on this page; it earns nothing from Noom.

Both begin with an online intake. Ro says it only charges the membership if you are eligible, and refunds the first month if you are not eligible for GLP-1s. Noom says a clinician evaluates the intake and prescribes if clinically appropriate, mainly by chat, and that it verifies identity and requires a full body photo before treatment.

Ro says cash-pay medication ships to your door and insured medication is picked up at your pharmacy. Noom says medication ships in 7 days if prescribed, that not all medications are available for home delivery, and that its partner pharmacies are USP-compliant and state-regulated; it does not name them.

If a provider cannot clearly explain who reviews your intake, how side effects are handled, or what happens when your refill is due, keep comparing before you proceed.

PCF separates clinical information from sponsored links. Some provider links may be sponsored, but all providers are described with cautious medical language: treatment may be available, consultation is required, and clinical appropriateness is determined by a licensed professional.

Provider details can change. Before starting any program, verify the current price, medication path, clinician credentials, pharmacy process, shipping terms, and follow-up support directly with the provider.